A B S T R A C T The metabolism of long chain fatty acids was investigated in the failing heart of guinea pigs with chronic constriction of the ascending aorta. Homogenates prepared from failing hearts exhibited (a) a decreased capacity to oxidize palmitic acid (failure = 0.50 ± 0.06 pmole/ g of protein per 20 min; control = 1.09 ± 0.10); (b) a reduced level of carnitine, a myocardial constituent which serves to control the oxidation rate of long chain fatty acids in the heart (failure = 0.91 + 0.10 umole/g wet weight; control = 1.69 + 0.10); and (c) an increased rate of palmitate incorporation into triglycerides and lecithin. Exogenous carnitine effected a restoration of the defective palmitate metabolism of the homogenates towards normal. In contrast to long chain fatty acid oxidation, glucose oxidation by the failing heart was not impaired. As a consequence of this selective lesion in energy substrate utilization, the failing heart might be forced to rely on substrates other than long chain fatty acids for its major energy supply.
INTRODUCTION
Long chain fatty acids constitute a major fraction of the energy-yielding substrates utilized by the heart (1) (2) (3) . From studies in man and the intact dog, several investigators have concluded that in the chronically failing heart, myocardial usage of lipids for energy production is not impaired (4, 5) . This conclusion, however, is subject to certain reservations since coronary sinus cathe-terization, the technique employed in these studies, has recognized limitations. Firstly, steady-state conditions must be assumed to prevail in measuring coronary blood flow and consequently in determining myocardial utilization of a substrate (6) ; secondly, the method provides no direct knowledge of the intermediate metabolism of the utilized substrate (7); and finally, the quantity of a substrate catabolized to CO2 and H2O is inferred from an oxygen extraction ratio (1) . In view of these limitations, the metabolism of lipids in the failing heart appeared to require a more direct evaluation.
The metabolism of long chain fatty acids by cardiac muscle from the failing heart was studied in myocardial homogenates from guinea pigs with chronic constriction of the ascending aorta. The data obtained provide evidence of a marked depression in the capacity of the failing heart to oxidize long chain fatty acids. In addition, the concentration of carnitine, a myocardial constituent that controls the rate of long chain fatty acid oxidation in the heart (8, 9) , was markedly reduced. Significantly, and in accord with recent studies on the failing heart in man and the experimental animal, no indication of impaired mitochondrial oxidative function was observed as a basis for the defect in lipid metabolism (10) (11) (12) .
METHODS
Heart failure was produced, with an established technique, in adult male guinea pigs weighing from 650 to 900 g by marked constriction of the ascending aorta (13, 14) .
2-mm clips were used for the constriction. Sham-operated animals were prepared by the same method except that the constricting aortic clip was removed immediately after application. A standard diet consisting of 50% Purina rabbit chow and 50% oats supplemented with fresh cabbage was offered to all operated animals and their con-trols. Body weights were recorded daily for at least 1 wk before the metabolic studies. Except for the immediate postoperative period, the operated animals gained body weight at a rate comparable to that shown by the controls.
16-39 days postoperatively, the treated animals and their controls were killed by a blow on the head. The pleural spaces were exposed to determine the presence of hydrothorax. The degree of reduction of the aortic lumen by the constricting clip was measured. The left ventricle together with the ventricular septum was freed from the great vessels, atria and right ventricle, blotted on filter paper, and weighed.
Left ventricles used to assess the effect of aortic constriction on myocardial protein, ribonucleic acid (RNA), and deoxyribonucleic acid (DNA) concentrations were homogenized in 30 ml of calcium-free Krebs-Ringer phosphate buffer, pH 7.4. Protein concentration was measured by the biuret method (15) , RNA by the orcinol method of Ceriotti (16) , and DNA by the p-nitrophenylhydrazine method of Webb and Levy (17) .
The capacity of left ventricular homogenates to oxidize selected substrates was assessed by collection of "4CO2 from "4C-labeled substrate as previously described (18) . Each constricted and sham animal used for an enzymatic assay was tested simultaneously with an untreated mate as a control. The homogenates were prepared so that the wet tissue weight per volume of homogenizing medium was approximately equal for the operated and control specimens. The specific activities of the palmitate and glucose in the reaction mixtures were estimated as follows: the concentration of free fatty acid in the myocardium was determined by the method of Amenta (19) and that of glucose by the procedure of Washico and Rice (20) . The myocardium from the failure animals contained 1.53 ± 0.11 umoles (mean ± SE) of free fatty acids per g wet weight, and from the controls, 2.25 ± 0.54. The values for glucose were 0.65 ± 0.15 Amole/g wet weight and 0.83 + 0.20, respectively. Since identical amounts of radioactive fatty acid or of glucose were added to the reaction mixtures, the specific activities of the respective substrates in the reaction mixtures at the beginning of the incubation period were considered equal. To determine whether or not the specific activity changed during the incubation period, time course experiments were done over an interval of 5-30 min. During incubation, the reaction rates were linear, and a fixed ratio of C02a evolved was maintained between the two groups.
This was considered to indicate that significant net lipolysis or glycogenolysis with dilution of the free fatty acid or glucose pools did not occur during the 20 min incubation period used in these experiments.
After the '4CO2 produced in the palmitate assay had been collected, the lipids in the reaction mixture were extracted as previously described (21) . The dried lipid extracts were dissolved in 1 ml of benzene. Glycerides, phospholipids, and palmityl carnitine were separated from the extracted lipids by thin-layer silica gel chromatography. A solvent system consisting of n-hexane: diethyl ether: glacial acetic acid (85: 15: 1) was used to separate triglycerides; phospholipids and palmityl carnitine were separated by a two-dimensional system as described previously (22). The chromatograms were stained by exposure to iodine vapor, and the areas corresponding to the desired lipid fractions were encircled. After the iodinestained spots had completely faded, the plates were sprayed with Neatan, (Brinkman Instruments, Westbury, N. Y.), and the encircled areas of silica gel were transferred to vials for scintillation counting. 12 ml of toluene containing 2,5-diphenyloxazole (PPO, 4 g/liter), 1,4 bis-[2-(5-phenyloxazolyl)]benzene (POPOP, 100 mg/liter), and 4% Cab-O-Sil thixotropic gel powder, Cabot Corporation, Boston, Mass., were used as the phosphor solution. Correction for quenching was carried out by the channel ratio method according to Bruno and Christian (23) .
Activity of the long chain fatty acid activating enzyme was assayed by the method of Kornberg and Pricer (24) and the activity of the long chain fatty acyl coenzyme A (CoA) carnitine transferase by the method of Fritz and Yue (25) . For these determinations, homogenates were prepared in 0.37 M sucrose and centrifuged at 2,000 rpm at 2-4°C for 10 min. Aliquots of the resulting supernatants were used.
Myocardial free and bound carnitine was extracted by the method of Pearson and Tubbs (26) . Carnitine concentration was determined enzymatically by the method of Marquis and Fritz (27) . The short chain fatty acyl
CoA carnitine transferase used in the carnitine assay was prepared from pigeon breast muscle by the procedure of Chase, Pearson, and Tubbs (28) .
Radioactive substrates: carboxyl-labeled palmitic acid, succinate-2,3-'4C,1 and glucose-U-14C 2 were obtained commercially. L-Palmityl carnitine was prepared by the method of Brendel and Bressler (29) , palmityl CoA by the method of Goldman and Vagelos (30) , and acetyl CoA by the method of Stadtman (31) . Nonradioactive palmitic acid,3 (-) -carnitine,4 coenzyme A,5 adenosine triphosphate (ATP),6 RNA, and DNAT -were purchased. As determined by gas liquid chromatography, the radioactive palmitate was 95% chemically pure and 98% radio pure.
The statistical significance of the data was evaluated by applying the t test to the mean differences between operated and control pairs or operated and control groups (32) .
RESULTS
Heart failure and left ventricular hvpertrophy. In the group of 14 guinea pigs with aortic constriction, the lumen of the ascending aorta was 'International Chemical and Nuclear Corp., City of Industry, Calif.
reduced to 5-15 % of normal at the constricted site.
Cardiac failure was manifested in each animal with aortic constriction by hydrothorax. The left ventricle was grossly hypertrophied in these animals as evidenced by wet weight, concentrations of protein, RNA and DNA, and the RNA: DNA ratio (Table I) .
None of three sham-operated animals or any of the 17 control guinea pigs had hydrothorax. The left ventricular weight in the sham-operated animals was not significantly different from the controls (sham = 1.59 + 0.05 [mean ± SEM] g/kg of body weight; control = 1.57 ± 0.05).
Long chain fatty acid oxidation. The rate of palmitate-1-_4C oxidation by homogenates prepared from the left ventricle of failure animals was reduced to less than one half of that shown by paired controls (Table II, Recently, the participation of a carnitine-palmityltransferase system has been implicated in the oxidation of activated palmitate groups by the heart (8, 25) . Accordingly, by means of the transesterification reaction:
palmityl CoA + (-)-carnitine carnitine-palmityltransferase (-)-palmityl carnitine + CoA activated palmitate groups are transported across a mitochondrial barrier which separates the sites of palmitate activation from intramitochondrial sites of oxidation. In comparing four animals in failure with paired controls, a significant difference in the activity of carnitine-palmityltransferase was not demonstrable (failure = 0.017 + 0.004 jamole of palmitylhydroxamate per mg of protein per 15 min; control = 0.017 + 0.002). On the other hand, the concentrations of free and total carnitine in the left ventricle of a group of six failure animals were reduced to approximately 50%o of control values (Table III) . The consequence of the reduced carnitine levels on the rate of palmitate-1-14C oxidation shown by the hearts of the failure animals is evidenced by the decreased rate of palmityl carnitine-14C formation by these preparations (Table IV) .
The addition of (-)-carnitine to the reaction mixtures doubled the rate of palmitate-1-'4C oxidation by the myocardium of the failure animals (Table II, that achieved when exogenous carnitine was added to the controls (Table II, 
columns 3 and 4).
The structural integrity of mitochondria is compromised by palmityl CoA in the absence of albumin due to the surface-active properties of palmityl CoA (25) . Incubation of the cardiac homogenates with palmityl CoA in the absence of albumin thereby affords a means by which activated palmitate groups can gain direct access to intramitochondrial oxidative pathways. Under these conditions, no differences between failure and control animals in the rate of palmityl CoA-14C oxidation was demonstrable (Table V) . When, however, bovine serum albumin was added to (Table  VI) . From these observations, it is inferred that an abnormality of the 8-oxidation mechanism, Krebs cycle, or electron transport system is not the basis of the depressed rate of palmitate oxidation in the failure animals. With albumin-protected mitochondria, however, a critical reduction of the myocardial carnitine concentration could limit the rate at which activated palmitate groups are trans- located from the extramitochondrial sites of activation to the intramitochondrial sites of oxidation and thereby results in the depressed rate of palmityl CoA oxidation observed in the failure animals.
Incorporation of palmitate-1-14C into myocardial lipids. In contrast to the rate of palmitate oxidation, the net rates of triglyceride-14C and of lecithin-14C synthesis were higher in the hearts of the failure animals than in the controls (Table VII) .
(-)-Carnitine decreased the rates of palmitate incorporated into these lipids in both the failure and control hearts. Only in the case of triglyceride, however, was the decrement effected by carnitine in the failure animals sufficient to decrease the rate of formation to that of the control.
Glucose and succinate oxidation. As shown in Table V, significant differences in the rates of glu- 
DISCUSSION
Long chain fatty acid oxidation in the failing heart of the guinea pig was characterized by (a) a depressed rate of palmitate oxidation, (b) a reduction in the concentration of carnitine, and (c) an increased rate of palmitate incorporation into triglyceride and lecithin. Long chain fatty acid oxidation. Decreased availability of ATP related to inefficient oxidative phosphorylation has been implicated as a metabolic basis of heart failure (14, (33) (34) (35) . Since ATP is required to convert long chain fatty acids into activated acyl groups in preparation for their oxidation by the heart, lack of ATP could have been t (-)-Carnitine.
Defective Lipid Metabolism in the Failing Heart responsible for the depressed rate of palmitate oxidation in the hearts of the guinea pigs with failure. The observations, however, that supplementary ATP did not improve the rate of palmitate oxidation and that glucose phosphorylation, as indicated by oxidation, was not impeded are inconsistent with this hypothesis. Furthermore, ATP, which is necessary for a carnitine-effected stimulation of long chain fatty acid oxidation (25) , was sufficiently abundant in these hearts to obtain an elevation of the depressed rate of palmitate oxidation when carnitine was added to these preparations. Thus, the evidence suggests that endogenously available ATP was not rate limiting in long chain fatty acid oxidation in these hearts. This is in accord with observations that myocardial levels of ATP are not decreased in the failing heart (10, 36) . The presence of defective Krebs cycle and electron transport activity has been observed in experimentally induced heart failure (37). In the current study the unimpeded oxidation of glucose and succinate and of palmityl CoA in the absence of albumin was considered to exclude abnormalities at these sites and in 8-oxidation as the basis of the depressed rate of palmitate oxidation. This conclusion is consistent with recent observations that mitochondria from the failing human heart and from animals with induced failure show normal oxidative function (10) (11) (12) .
The participation of carnitine in long chain fatty acid oxidation is supported by evidence from several laboratories (25, 38, 39) . Carnitine, which is almost ubiquitous in mammalian tissues, is especially abundant in muscle (40) . In the heart, palmitate and palmityl CoA oxidation appear to be completely dependent on the presence of carnitine (9), the rate of oxidation being controlled by the carnitine concentration (8) . According to current concepts, this regulatory function is mediated by the formation of acyl carnitine derivatives which serve to effect the transport of activated acyl groups across a mitochondrial barrier from sites of activation to those of oxidation (25, 38) .
In the guinea pigs with heart failure, the levels of carnitine in the left ventricle were markedly reduced. That these depressed levels of carnitine were rate limiting in palmitate oxidation in these hearts is evidenced by (a) the location of the defect in the long chain fatty acid oxidation pathway, (b) the depressed rate of palmityl CoA oxidation in homogenates containing albumin and the unimpaired rate in homogenates whose mitochondria were not protected by albumin, and (c) the depressed rate of palmityl carnitine-14C formation from palmitate-1-14C.
Although supplementary carnitine was capable of elevating the rate of palmitate oxidation by the failing hearts to control levels, the rates achieved were not equivalent to those of the controls to which exogenous carnitine was added. This finding suggests that other factors might have limited the rate of long chain fatty acid oxidation in the failing hearts. In the isolated perfused heart, the conversion of palmitate to CO2 can be stimulated by norepinephrine (41) . Since norepinephrine levels are markedly reduced in the failing heart (42-44), catecholamine depletion may also have played a role in limiting the rate of long chain fatty acid oxidation in the failing preparations.
Long chain fatty acid esterification. In contrast to its lower rate of palmitate oxidation, the failing heart showed a higher rate of palmitate incorporation into lecithin and triglyceride than the controls. Of the total amount of palmitate converted to identified end products, 39% was present as esters in the failing heart, whereas in the controls this value was 17. It is possible that had additional myocardial lipids been investigated, an even greater percent of the total palmitate used by the failing heart would have been detected in esterified form. This quantitative redistribution of the palmitate metabolized by the failing heart suggests that although the total amount of plasma lipid taken up by the failing heart might not be different from the normal (1), the percent utilized for immediate energy production is greatly reduced.
On addition of exogenous carnitine to the reactions, the rates of palmitate esterification decreased in both the failing heart and control. Since carnitine has no direct effect on the incorporation of palmitate into glycerides, the decrease effected by carnitine is considered to be secondary to the concurrent increase in the rate of palmitate oxidation (45) . This finding may indicate that the palmitate which is converted to triglyceride when the carnitine concentration is suboptimal in the failing heart is redirected to oxidation when the carnitine concentration is raised. A similar mechanism may ap-ply in the case of lecithin formation in the guinea pig heart, although no effect of carnitine on the rate of palmitate incorporation into lecithin has been demonstrated in either beef heart mitochondria or rat heart homogenates (46, 47) . Nutritional status. Even though maintenance of body weight was similar in both failure and control groups, the possibility was considered that fluid accumulation could have obscured a loss of tissue mass in the failure animals and, thus, that an altered nutritional state was responsible for the observed changes in lipid metabolism. Weight loss due to either restriction of caloric intake or increased metabolic demand, however, is associated with enhanced rather than depressed rates of long chain fatty acid oxidation by the heart (48, 49) and increased levels of carnitine palmityltransferase activity (49, 50) . Thus, it appears unlikely that the defective lipid metabolism demonstrated in the failing heart resulted from an abnormal nutritional state.
Cardiac failure and hypertrophy. The possibility exists that the hypertrophic response of the heart due to aortic constriction, rather than the failure, was related to the observed defects in long chain fatty acid metabolism. Although this cannot be excluded, the hypertrophied hearts of hyperthyroid guinea pigs show increased rather than decreased rates of palmitate oxidation and levels of carnitine, increased rather than unaltered activity of carnitine palmityltransferase, and decreased rather than unimpaired rates of glucose oxidation (49) . Thus, it would appear unlikely that ventricular hypertrophy per se is the basis of the abnormal lipid metabolism observed in the heart failing consequent to aortic constriction.
